Sign in
4

Changes in Ownership

Avalo Therapeutics, Inc. Filed Acc 0001578563-19-000038

Chief Commercial Officer bought 3,064 shares at $2.85 ($8,725)

From the SEC's structured data for this filing

Trades in this filing

Harrell James Archie Jr · Chief Commercial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2019-12-10 Purchase : show line 1 in the form +3,064 $2.85 $8,725 11,618 D
Open-market purchases · 3,064 sh · avg $2.85 · $8,725
Loading xslF345X03/primary_doc.xml…